Showing 361 - 380 results of 2,473 for search '"osteosarcoma"', query time: 0.12s Refine Results
  1. 361
  2. 362

    Single-Cell Transcriptome Analysis Reveals Paraspeckles Expression in Osteosarcoma Tissues by Emel Rothzerg, Wenyu Feng, Dezhi Song, Hengyuan Li, Qingjun Wei, Archa Fox, David Wood, Jiake Xu, Yun Liu

    Published 2022-12-01
    “…To this date, there are limited findings to suggest that paraspeckles, NEAT1 and heterogeneous nuclear ribonucleoproteins (hnRNPs) directly or indirectly play roles in osteosarcoma progression. Herein, we analysed NEAT1, paraspeckle proteins (SFPQ, PSPC1 and NONO) and hnRNP members (HNRNPK, HNRNPM, HNRNPR and HNRNPD) gene expression in 6 osteosarcoma tumour tissues using the single-cell RNA-sequencing method. …”
    Get full text
    Article
  3. 363
  4. 364
  5. 365
  6. 366
  7. 367
  8. 368
  9. 369
  10. 370
  11. 371
  12. 372
  13. 373

    Different Microfluidic Environments for In Vitro Testing of Lipid Nanoparticles against Osteosarcoma by Oihane Mitxelena-Iribarren, Sara Lizarbe-Sancha, Jay Campisi, Sergio Arana, Maite Mujika

    Published 2021-06-01
    “…Thus, the results obtained with the microfluidic model present MTX-lipid nanoparticles as a promising and more effective therapy for pediatric osteosarcoma treatment than current treatment options.…”
    Get full text
    Article
  14. 374

    ANTI-TUMOR EFFECTS OF SIMVASTATIN ON UMR-106 OSTEOSARCOMA CELL LINE by María Claudia Sandoval-Usme, Natalia Ordóñez, Adriana Umaña-Pérez, Leandro Fernández-Pérez, Myriam Sánchez-Gómez

    Published 2023-12-01
    “…In this study, we used malignant UMR-106 osteosarcoma cells and normal HTR8/SVneo extravillous trophoblast cells, and found that simvastatin decreases cell viability in a dose and time-dependent manner in both cell types. …”
    Get full text
    Article
  15. 375
  16. 376

    Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms by Guibin Li, Jie Lei, Dexin Xu, Wenchang Yu, Jinping Bai, Ge Wu

    Published 2023-04-01
    “…Abstract Osteosarcoma (OS) is the most common primary malignant bone tumor with high metastatic potential and relapse risk. …”
    Get full text
    Article
  17. 377
  18. 378
  19. 379
  20. 380